133 related articles for article (PubMed ID: 3492218)
1. Characterisation of a new murine B cell lymphoma.
Cobb LM; Glennie MJ; McBride HM; Breckon G; Richardson TC
Br J Cancer; 1986 Nov; 54(5):807-18. PubMed ID: 3492218
[TBL] [Abstract][Full Text] [Related]
2. B-lymphocyte heterogeneity: ontogenetic development and organ distribution of B-lymphocyte populations defined by their density of surface immunoglobulin.
Scher I; Sharrow SO; Wistar R; Asofsky R; Paul WE
J Exp Med; 1976 Aug; 144(2):494-506. PubMed ID: 822116
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. I. T cells derived from Peyer's patches that switch sIgM B cells to sIgA B cells in vitro.
Kawanishi H; Saltzman LE; Strober W
J Exp Med; 1983 Feb; 157(2):433-50. PubMed ID: 6185611
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 15 trisomy in spontaneous and carcinogen-induced murine lymphomas of B-cell origin.
Wiener F; Babonits M; Spira J; Bregula U; Klein G; Merwin RM; Asofsky R; Lynes M; Haughton G
Int J Cancer; 1981 Jan; 27(1):51-8. PubMed ID: 6788720
[TBL] [Abstract][Full Text] [Related]
5. The expression of B cell surface receptors. I. The ontogeny and distribution of the murine B cell IgE Fc receptor.
Waldschmidt TJ; Conrad DH; Lynch RG
J Immunol; 1988 Apr; 140(7):2148-54. PubMed ID: 2965179
[TBL] [Abstract][Full Text] [Related]
6. X-linked B-lymphocyte defect in CBA/N mice. III. Abnormal development of B-lymphocyte populations defined by their density of surface immunoglobulin.
Scher I; Sharrow SO; Paul WE
J Exp Med; 1976 Aug; 144(2):507-18. PubMed ID: 822117
[TBL] [Abstract][Full Text] [Related]
7. Influences of the microenvironment on B-cell responses of wasted mice: comparison of Peyer's patches and mesenteric lymph nodes.
Woloschak GE; Krco CJ; Rodriguez M
Reg Immunol; 1988; 1(3):163-71. PubMed ID: 2908589
[TBL] [Abstract][Full Text] [Related]
8. A murine B-cell lymphoma induced by Gross virus.
Numata M; Mitsuboshi Y; Nitta K
Cancer Res; 1981 Apr; 41(4):1492-6. PubMed ID: 6971147
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro.
Maloney DG; Kaminski MS; Burowski D; Haimovich J; Levy R
Hybridoma; 1985; 4(3):191-209. PubMed ID: 3899906
[TBL] [Abstract][Full Text] [Related]
10. Idiotype vaccination leads to the emergence of a stable surface Ig-negative variant of the mouse lymphoma BCL1, with different growth characteristics.
George AJ; Spellerberg MB; Stevenson FK
J Immunol; 1988 Mar; 140(5):1695-701. PubMed ID: 3162250
[TBL] [Abstract][Full Text] [Related]
11. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
[TBL] [Abstract][Full Text] [Related]
12. The expression of membrane and secreted immunoglobulin during the in vitro differentiation of the murine B cell lymphoma CH12.
Stockdale AM; Dul JL; Wiest DL; Digel M; Argon Y
J Immunol; 1987 Nov; 139(10):3527-35. PubMed ID: 3500220
[TBL] [Abstract][Full Text] [Related]
13. Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (centrocytes).
Tolksdorf G; Stein H; Lennert K
Br J Cancer; 1980 Feb; 41(2):168-82. PubMed ID: 7370158
[TBL] [Abstract][Full Text] [Related]
14. Lymphoma models for B cell activation and tolerance. I. Conditions for the anti-mu-dependent stimulation of growth in NBL, a nude B cell lymphoma.
Ling M; Livnat D; Pillai PS; Scott DW
J Immunol; 1985 Mar; 134(3):1449-54. PubMed ID: 2578509
[TBL] [Abstract][Full Text] [Related]
15. Treatment of the murine lymphoma A31 with intravenous, sterilized, 114mIn-loaded A31 cells.
Cobb LM; Butler SA
Radiother Oncol; 1987 Nov; 10(3):217-30. PubMed ID: 3124221
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of mouse B lymphocytes: studies using in vitro response to lipopolysaccharide.
Lamelin JP; Vassalli P
Ann Immunol (Paris); 1975; 126(5-6):523-39. PubMed ID: 132134
[TBL] [Abstract][Full Text] [Related]
17. Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity.
Arnold LW; LoCascio NJ; Lutz PM; Pennell CA; Klapper D; Haughton G
J Immunol; 1983 Oct; 131(4):2064-8. PubMed ID: 6194226
[TBL] [Abstract][Full Text] [Related]
18. Karyotype evolution in B-cell lymphoid malignancy with an 8;14 translocation.
Fukuhara S; Kita K; Nasu K; Kannagi M; Kamezaki T; Ohno H; Yamazowa M; Nishigori M; Uchino H; Yagita M
Int J Cancer; 1983 Nov; 32(5):555-62. PubMed ID: 6605942
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. II. Terminal differentiation of postswitch sIgA-bearing Peyer's patch B cells.
Kawanishi H; Saltzman L; Strober W
J Exp Med; 1983 Sep; 158(3):649-69. PubMed ID: 6604126
[TBL] [Abstract][Full Text] [Related]
20. Expression, distribution and specificity of Fc receptors for IgM on murine B cells.
Mathur A; Lynch RG; Köhler G
J Immunol; 1988 Sep; 141(6):1855-62. PubMed ID: 2971716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
